Home › Funds › UBS Group AG › ENTO
UBS Group AG position in ENTO
ENTERO THERAPEUTICS INC
Latest position (Q2 2025)20.55K sh
Reported value held$8.22K
Portfolio Weight0.00%
First reportedQ4 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 1.54K | $6.46K | New |
| Q2 2024 | 449 | $552 | New |
| Q3 2024 | 1 | $0 | Reduce |
| Q4 2024 | 7.53K | $4.68K | Add |
| Q1 2025 | 57.98K | $27.83K | Add |
| Q2 2025 | 20.55K | $8.22K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.